Today's Healthcare Pulse
FDA greenlights durvalumab combo for high‑risk bladder cancer
The FDA approved durvalumab (Imfinzi) combined with Bacillus Calmette‑Guerin for BCG‑naïve, high‑risk non‑muscle invasive bladder cancer. The POTOMAC trial enrolled 1,018 patients and showed a 32% reduction in disease recurrence risk (hazard ratio 0.68, p=0.015). Durvalumab is given at 1,500 mg IV every four weeks for up to 13 cycles.
Also developing:
By the numbers: Apogee Therapeutics raises $1.3B royalty financing
Swapping Passive Screen Time with Mental Activity May Cut Dementia Risk
A 19‑year Swedish cohort study of 20,811 adults found that mentally active sedentary behavior, such as reading or puzzles, lowered dementia risk compared with passive screen time. Each additional hour of mental activity was linked to a 4% risk reduction, and substituting one hour of TV with mental tasks cut risk by 7%. The analysis adjusted for lifestyle and health factors, while physical activity showed no statistically significant association with dementia in this sample. These findings suggest everyday cognitive engagement may be a practical preventive strategy.
Rapamycin Fails to Slow Epigenetic Aging, Sinclair Concedes
David Sinclair says rapamycin had no measurable effect on slowing or reversing epigenetic aging in humans. This was a drug most of the longevity community supported. He was even a believer of it. It was found to extend lifespan in: • Inbred lab animals •...
Re: Doctors Condemn Expansion of GMC’s Appeal Powers After Government “Betrayal”
Doctors have publicly condemned the UK government’s decision to broaden the General Medical Council’s (GMC) appeal powers, calling it a betrayal of professional trust. An independent review commissioned by the GMC, led by Norman Williams, had previously recommended that the regulator...
Speak Up Safely: Observe, Report, Protect Clinical Culture
No surgeon. No anesthesiologist. One physician. Packed ED. @jessicasinghmd stabilized a critically ill patient with blood in their airway. Shift ends. The incoming physician, also an administrator, says in front of staff: "I need you to function." She reported it....
View mRNA‑CRISPR as Molecular Surgery, Not Drugs
What if we started thinking of mRNA-CRISPR gene editing as molecular surgery, not as a pharmaceutical product? Excellent @nytimes guest essay ⤵️ https://t.co/S61XwNRVZF
Scientists Discover Hidden Gut Trigger Behind ALS and Dementia
Case Western Reserve University researchers have identified a gut‑brain mechanism linking harmful bacterial glycogen to neuronal loss in amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). In a study of 23 patients, 70% exhibited elevated levels of this inflammatory sugar,...
This Is a Tale of Two Outbreaks. The Difference Is RFK Jr.
A raw‑milk cheddar cheese outbreak linked to E. coli O157:H7 surfaced in March 2026, prompting the FDA to issue a recall recommendation. The producer, citing alleged scientific bias, refused to withdraw the product, echoing rhetoric championed by political activist Robert F. Kennedy Jr. The...
Vanda Pharmaceuticals Initiates Thetis Study of Nereus for GLP-1–Induced Vomiting Prevention
Vanda Pharmaceuticals has launched the Phase‑III Thetis trial to test Nereus (tradipitant) against placebo for preventing vomiting in patients on GLP‑1 receptor agonists. The study’s primary endpoint is the proportion of participants who remain vomiting‑free, with topline data slated for...
Weight‑loss Drug Semaglutide Cuts Depression Risk by 42%
A 10-year study finds weight-loss drugs lower the risk of #depression and anxiety. Published in The Lancet Psychiatry, the #research revealed a 42% lower risk of #mentalhealth hospitalisation during periods of semaglutide use. https://t.co/CphnQl0Khx
EU Launches PsyPal Project to Test Psychedelic Therapy for Palliative Care Distress
The European Commission announced the launch of the EU‑funded PsyPal project, a clinical research programme that will evaluate psychedelic therapy for psychological distress in palliative‑care patients. The initiative, unveiled on 13 April 2026 at the Directorate‑General for Health and Food Safety, signals...
Why Anti-Cancer Drugs Often Fall Short of Expectations
Recent analyses reveal that many anti‑cancer drugs underperform because they confront complex tumor biology that preclinical studies often oversimplify. Heterogeneous cell populations, rapid emergence of resistance pathways, and inadequate biomarker strategies limit clinical efficacy. Additionally, safety concerns restrict dose intensity,...
N. Carolina Greenlights Two Hospital Projects Worth over $500M
North Carolina’s Department of Health and Human Services approved two major hospital projects near Asheville, totaling over $500 million. Mission Hospital will add up to 95 acute‑care beds, raising its capacity to 828, with an estimated cost of more than $198 million...
Contributor: Vaccine Confusion Sets up U.S. for a Resurgence of Hepatitis B in Babies
New research shows U.S. newborn hepatitis B vaccination rates dropped more than 10% between 2023 and August 2025. The federal Advisory Committee on Immunization Practices recently changed its guidance, moving the newborn dose from a universal recommendation to a case‑by‑case decision for...
Prospect Medical Collapse Highlights Private‑Equity Risks in For‑Profit Hospital Chains
Prospect Medical, a 17‑hospital chain owned by private‑equity investors, filed for bankruptcy after a debt‑laden expansion left it owing over $135 million in taxes and without malpractice insurance reserves. The fallout underscores systemic risks in PE‑backed health‑care assets.
Eli Lilly's Foundayo Oral GLP‑1 Gets FDA Nod, Targets $2 B U.S. Sales in 2026
Eli Lilly announced that the FDA approved its once‑daily oral GLP‑1 pill Foundayo (orforglipron) for chronic weight management, ahead of the April 10 PDUFA deadline. The drug is priced from $25 to $349 a month and analysts project $1.2‑$2 billion in...
Employers Have Helped Rein in Healthcare Costs, but the Fight Isn’t Over
U.S. employers, benefits advisors, and health‑care suppliers have largely succeeded in flattening health‑care cost growth between 2010 and 2024. While CMS actuaries projected 168 million covered workers at $9,556 per participant, actual employer‑sponsored plans covered 179 million people at an average $8,002,...
Australian Startup Sonorus Deploys AI to Spot Rheumatic Heart Disease in Minutes
Sonorus, an Australian health‑tech startup, demonstrated an artificial‑intelligence algorithm at SXSW Sydney that can flag rheumatic heart disease from a brief audio recording of heart sounds. The low‑cost tool promises rapid, portable screening for communities where the disease remains prevalent,...
California Man Pleads Guilty to $270 Million Medi‑Cal Prescription Drug Fraud
Paul Randall, a 66‑year‑old Orange County resident, pleaded guilty to submitting nearly $270 million in fraudulent Medi‑Cal claims for costly, medically unnecessary prescription drugs. The scheme, run through Monte Vista Pharmacy with a pharmacist and a nurse practitioner, underscores deep vulnerabilities...
Baystate Franklin Nurses Picket Over Pay Gap and Staffing Ratios
Baystate Franklin Medical Center nurses, representing roughly 240 staff members, started a picket on Tuesday to pressure Baystate Health into a new contract that addresses a 16%‑23% wage gap and preserves nurse‑patient ratios. The action comes as the current contract...
High Dose Influenza Vaccine Correlates with Greater Reduction in Dementia Risk
A retrospective cohort study of U.S. seniors found that receiving a high‑dose inactivated influenza vaccine (H‑IIV) was associated with a significantly lower risk of Alzheimer’s disease compared with the standard‑dose vaccine (S‑IIV). The analysis used claims data from 2014‑2019, covering...
Why Was a Florida Woman Forced to Have a C-Section? | Tayo Bero
A ProPublica investigation revealed that two Black women in Florida, including doula Cherise Doyley, were forced into cesarean sections despite clear refusals, after a court permitted emergency surgery in the name of the unborn child. The case illustrates how state...
Grail’s $824 Liquid Biopsy Test Sparks Debate Over Accuracy and Cost
A first‑hand account of a $824 Galleri liquid‑biopsy screening test from Grail has ignited a fresh debate over the technology’s clinical value and price point. The test, which claims to detect more than 50 cancers, delivered a 51.5% overall detection...
Ready to Rethink the Bias Embedded in Prevention?
A new paper in *Current Obesity Reports* challenges the entrenched bias that frames obesity prevention as a matter of personal responsibility. It argues that decades of investment in “eat less, move more” campaigns have failed because they ignore the complex...
How the Care Gap Fuels Claims and Costs in Long-Term Care
The long‑term care (LTC) sector faces a deepening staffing shortage that is now a balance‑sheet liability, driving higher claim frequencies and premium increases for insurers. Demographic trends predict that 20% of Americans will be 65 or older by 2030, while...
How Does the Complexity of Obesity Impact the Effectiveness of GLP-1s?
The FDA granted accelerated approval for a high‑dose injectable version of Wegovy, while Novo Nordisk introduced a multi‑month subscription model aimed at telehealth prescribers. New data from Phenomix and the Mayo Clinic reveal that many patients lack a clear understanding...
Granules India to Tighten Oversight After US FDA Warning, Exec Says
Granules India, a leading global paracetamol and API producer, is tightening oversight after the U.S. FDA cited GMP, equipment cleaning and record‑keeping violations at its Telangana plant. The company will digitise logbooks, batch records and badge cards, increase gemba walks,...
Microplastics Found in Human Bile May Be Associated with Gallstones
Researchers detected microplastic particles in human bile for the first time, with polyethylene terephthalate (PET) and polyethylene (PE) comprising the majority. In a small cohort, patients with gallstones exhibited a markedly higher microplastic load than controls. Laboratory exposure of cholangiocytes...
How to Make Cancer Therapies BETter: An Insight Into the Distinct Roles of BET Proteins
A new study from the Max Planck Institute reveals that BET proteins BRD2 and BRD4 play distinct, sequential roles in gene activation, explaining why broad‑spectrum BET inhibitors have shown limited clinical success. BRD4 drives the release of RNA polymerase II,...
20 Future Czech HealthTech and MedTech Leaders
The Czech Republic’s healthtech and medtech sectors are shifting from fragmented early‑stage projects to profit‑focused, clinically validated businesses, positioning the country as a global contender. Despite a 7.7% drop in total startup investment to €540 million (≈$589 million) in 2025, the healthtech...
EP506: How Other Employers, Shareholders, and Clinics Are Using Price Transparency Data—And It's an Arms Race, With Jerry DiMaso
In this episode, Stacey Richter talks with Jerry DeMasso, CEO of Payerset, about how price‑transparency data is reshaping the healthcare market for self‑insured employers, plan sponsors, and clinical organizations. DeMasso explains three key insights employers can gain: benchmarking against competitors,...
Breathing New Life Into Tubercolosis Treatment with Iinhalable Nanomedicine
Scientists at the University of Witwatersrand’s Wits Advanced Drug Delivery Platform have created an inhalable nanocarrier that can encapsulate all four first‑line tuberculosis drugs and release them directly in the lungs. The system bypasses the liver and bloodstream, aiming to...
Octopus-Shaped Nanomachine Reprograms ATP Flow to Starve Cancer Cells
Researchers unveiled an octopus‑shaped nanomachine, HSA‑ABC, that anchors to cancer cell membranes and uses an ATP‑sensing aptamer to trigger photodynamic therapy and rapid doxorubicin delivery. The device creates a self‑amplifying cycle: ATP binding activates a photosensitizer, damaging the membrane, which...
FDA Seeks Permanent Future for Rare Pediatric Priority Review Vouchers
The FDA announced plans to permanently authorize the rare pediatric disease priority‑review voucher (PRV) program as part of its $7.2 billion FY 2027 budget request. The initiative ends the cycle of four‑year reauthorizations that left the program in limbo after its 2024...
Study Shows That Vitamin D In Your 40s Is Linked To Alzheimer's-Like Brain Changes
A new analysis of the Framingham Heart Study Generation 3 cohort found that higher vitamin D levels measured in participants' late thirties were linked to lower tau protein accumulation sixteen years later, a hallmark of early Alzheimer’s pathology. The same vitamin D measurements...
Holland & Barrett Brings Proactive Care to Consumers with Wellness Check-Ins and Diagnostics
Holland & Barrett is rolling out a free "Wellness Check‑In" service for consumers under 40, pairing in‑store experts with paid diagnostic tests from Randox Health. The launch follows an Ipsos report showing 45% of Britons only act on health when something...
US Market to Dent India Pharma Earnings Even as Domestic Growth Remains Firm: Report
Nuvama Institutional Equities forecasts Indian pharmaceutical revenue to rise 10% YoY in FY 26, with EBITDA up 3% but PAT falling 6% as margin pressure intensifies. Domestic sales are projected to expand 12% YoY, driven by strong cardiac, anti‑diabetic and oncology...
Signature Healthcare Cyberattack Causes Service Disruptions, Treatment Delays
Signature Healthcare detected a cyberattack on April 6, 2026, prompting the network to shift to emergency downtime procedures. The breach forced the Brockton Hospital to divert ambulances, cancel chemotherapy infusions, and rely on manual workflows, while surgeries and urgent care continued...
“I Don’t Need Those Pills”—Until the Second Heart Attack
At ACC 2026, researchers unveiled the Ez‑PAVE trial, a multicenter, randomized study of 3,048 South Korean patients with established atherosclerotic cardiovascular disease. The trial compared an ultra‑low LDL‑C target of <40 mg/dL against a conventional target of <70 mg/dL, using statin plus...
Farm Bureau Plans Are a Less Pricey Alternative to ACA Coverage — With Trade-Offs
Rising ACA premiums are pushing consumers toward lower‑cost alternatives, such as farm bureau health plans now available in Missouri and 13 other states. Membership in a state farm bureau costs $30‑$50 annually and grants access to plans that can be...
How to Make a High-Deductible Health Plan and HSA Work for You
When federal ACA subsidies expired in 2025, many consumers turned to high‑deductible health plans (HDHPs) to keep premiums low, despite facing potentially large out‑of‑pocket costs. The share of workers with HDHPs rose to 30% in 2023, up from just 4%...
Pharma Pulse: Tariffs, a Ceasefire, and Patient Access
The U.S. Commerce Department announced a 100% base tariff on imported active pharmaceutical ingredients and patented drugs, urging manufacturers to shift production domestically. Companies can avoid the full rate by securing a most‑favored‑nation pricing agreement or by filing an onshoring...
For-Profit Hospital Chain Never Put Aside Money for Malpractice Insurance to Compensate Injured Patients
Prospect Medical, a private‑equity‑backed for‑profit hospital chain, filed for bankruptcy in January 2025 after a debt‑laden expansion left it unable to fund malpractice insurance. Court filings reveal the company never set aside reserves to cover legal defenses or settlements, leaving...
States Face Another Challenge With Medicaid Work Rules: Staffing Shortages
Congressional Republicans’ One Big Beautiful Bill Act, signed by President Trump, will impose new Medicaid work requirements that take effect for most states on Jan. 1, 2027. The rule shifts eligibility verification from annual to semi‑annual checks and adds a workload...
TyG/AIP Indices Linked to Survival in Elderly Patients
The 2026 BMC Geriatrics study linked cumulative triglyceride‑glucose (TyG) and atherogenic index of plasma (AIP) metrics to terminal survival in patients aged 65 and older with circulatory system diseases. By tracking serial blood‑test data, researchers identified a clear dose‑response: higher...
BIO Coffee Chat: Price Controls Like MFN Harm Access, Increase Costs
BIO’s March Coffee Chat highlighted how recent U.S. drug‑price policies, including the Inflation Reduction Act’s out‑of‑pocket cap and proposed Most Favored Nation (MFN) pricing models, are unintentionally raising patient costs and tightening access. Evidence shows beneficiaries often pay more than...
Astellas Exercises Option to License Dyno’s AAV Capsid for AI-Designed Gene Delivery
Astellas has exercised its option to license an AI‑engineered adeno‑associated virus (AAV) capsid from Dyno Therapeutics for skeletal muscle gene delivery, marking the first licensed asset from their 2021 partnership. The capsid, created using Dyno’s large‑scale in‑vivo data‑driven AI models,...
Making Bricks From Straw
A randomized field experiment in Nigeria gave 600,000 ₦ (≈ $1,300) grants to public health clinics, letting staff control the money over a year. The autonomous funding spurred sizable productivity gains, with clinics investing in both physical assets and staff development. Patient...
Autoregressive Models for Panel Data Causal Inference with Application to State-Level Opioid Policies
A team of researchers introduced an autoregressive framework for causal inference in panel data, targeting the evaluation of state‑level opioid policies. The method addresses staggered adoption and limited sample sizes that hinder traditional difference‑in‑differences and synthetic‑control approaches. Simulations mirroring real‑world...
Between Doubt and Diagnosis
A qualitative study of 23 patients who experienced delayed diagnoses across five conditions reveals that emotional fallout outweighs clinical consequences. Most participants felt dismissed by clinicians, fueling frustration, anger, and self‑doubt. Receiving a definitive diagnosis provided relief and validation, yet...
Korea to Pilot AI-Driven Telemedicine in Indonesia
South Korea and Indonesia have signed a memorandum of understanding to launch AI‑driven teleconsultation pilots in Indonesia’s remote island communities. The partnership targets AI‑based primary healthcare, including public health, maternal‑child care, mental health, and digital wellness, with involvement from university...